137 related articles for article (PubMed ID: 24848085)
1. Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.
de Decker L; Campone M; Retornaz F; Berrut G; Kabeshova A; Molinié F; Beauchet O
PLoS One; 2014; 9(5):e98127. PubMed ID: 24848085
[TBL] [Abstract][Full Text] [Related]
2. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
Sant M; Meneghini E; Bastos J; Rossi PG; Guevara M; Innos K; Katalinic A; Majuelo LG; Marcos-Gragera R; Molinié F; Rapiti E; Vizcaino A; Zadnik V; Minicozzi P;
Breast Cancer Res Treat; 2020 Sep; 183(2):439-450. PubMed ID: 32651753
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Hormone Receptor Status (ER/PR/HER2-neu) in Breast Cancer in Pakistan.
Pervaiz F; Rehmani S; Majid S; Anwar H
J Pak Med Assoc; 2015 Jul; 65(7):747-52. PubMed ID: 26160085
[TBL] [Abstract][Full Text] [Related]
4. Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Chakraborty A; Bose CK; Basak J; Sen AN; Mishra R; Mukhopadhyay A
Indian J Med Res; 2016 May; 143(Supplement):S45-S51. PubMed ID: 27748277
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
6. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
[TBL] [Abstract][Full Text] [Related]
7. Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.
Dowsett M; Houghton J; Iden C; Salter J; Farndon J; A'Hern R; Sainsbury R; Baum M
Ann Oncol; 2006 May; 17(5):818-26. PubMed ID: 16497822
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of known prognostic factors in female breast carcinoma including oestrogen receptor, progesterone receptor and Her-2/neu status--a study in a tertiary care centre.
Chakrabarti S; Karmakar R; Barui G; Maity PK; Bandyopadhyay A; Roy A
J Indian Med Assoc; 2012 Dec; 110(12):876-9. PubMed ID: 23936949
[TBL] [Abstract][Full Text] [Related]
9. A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.
Skliris GP; Nugent ZJ; Rowan BG; Penner CR; Watson PH; Murphy LC
Endocr Relat Cancer; 2010 Sep; 17(3):589-97. PubMed ID: 20418363
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
Hilborn E; Gacic J; Fornander T; Nordenskjöld B; Stål O; Jansson A
Br J Cancer; 2016 Feb; 114(3):248-55. PubMed ID: 26742006
[TBL] [Abstract][Full Text] [Related]
11. Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.
Das K; Leong DT; Gupta A; Shen L; Putti T; Stein GS; van Wijnen AJ; Salto-Tellez M
Eur J Cancer; 2009 Sep; 45(13):2239-48. PubMed ID: 19632824
[TBL] [Abstract][Full Text] [Related]
12. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
14. Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
Bertaut A; Mounier M; Desmoulins I; Guiu S; Beltjens F; Darut-Jouve A; Ponnelle T; Arnould L; Arveux P
Eur J Cancer Care (Engl); 2015 Nov; 24(6):920-8. PubMed ID: 25757548
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Saura C; Hlauschek D; Oliveira M; Zardavas D; Jallitsch-Halper A; de la Peña L; Nuciforo P; Ballestrero A; Dubsky P; Lombard JM; Vuylsteke P; Castaneda CA; Colleoni M; Santos Borges G; Ciruelos E; Fornier M; Boer K; Bardia A; Wilson TR; Stout TJ; Hsu JY; Shi Y; Piccart M; Gnant M; Baselga J; de Azambuja E
Lancet Oncol; 2019 Sep; 20(9):1226-1238. PubMed ID: 31402321
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity burden and guideline-concordant care for breast cancer.
Kimmick G; Fleming ST; Sabatino SA; Wu XC; Hwang W; Wilson JF; Lund MJ; Cress R; Anderson RT;
J Am Geriatr Soc; 2014 Mar; 62(3):482-8. PubMed ID: 24512124
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
18. Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.
Ugiagbe EE; Obaseki DE; Oluwasola AO; Olu-Eddo AN; Akhiwu WO
Niger Postgrad Med J; 2012 Mar; 19(1):19-24. PubMed ID: 22430597
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
[TBL] [Abstract][Full Text] [Related]
20. Correlation of human epidermal growth factor receptor 2 (HER-2/neu) receptor status with hormone receptors Oestrogen Receptor, Progesterone Receptor status and other prognostic markers in breast cancer: an experience at tertiary care hospital in Karachi.
Mujtaba S; Haroon S; Faridi N; Lodhi FR
J Pak Med Assoc; 2013 Jul; 63(7):854-8. PubMed ID: 23901708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
